123 related articles for article (PubMed ID: 30321321)
1. Selective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male Mice.
Koorneef LL; van den Heuvel JK; Kroon J; Boon MR; 't Hoen PAC; Hettne KM; van de Velde NM; Kolenbrander KB; Streefland TCM; Mol IM; Sips HCM; Kielbasa SM; Mei H; Belanoff JK; Pereira AM; Oosterveer MH; Hunt H; Rensen PCN; Meijer OC
Endocrinology; 2018 Dec; 159(12):3925-3936. PubMed ID: 30321321
[TBL] [Abstract][Full Text] [Related]
2. A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet.
Mammi C; Marzolla V; Armani A; Feraco A; Antelmi A; Maslak E; Chlopicki S; Cinti F; Hunt H; Fabbri A; Caprio M
Int J Obes (Lond); 2016 Jun; 40(6):964-72. PubMed ID: 26830012
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined glucocorticoid/mineralocorticoid receptor modulation (CORT118335) on energy balance, adiposity, and lipid metabolism in male rats.
Nguyen ET; Berman S; Streicher J; Estrada CM; Caldwell JL; Ghisays V; Ulrich-Lai Y; Solomon MB
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E337-E349. PubMed ID: 31112405
[TBL] [Abstract][Full Text] [Related]
4. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of imipramine and CORT118335 (Glucocorticoid receptor modulator/mineralocorticoid receptor antagonist) on brain-endocrine stress responses and depression-like behavior in female rats.
Nguyen ET; Caldwell JL; Streicher J; Ghisays V; Balmer NJ; Estrada CM; Solomon MB
Behav Brain Res; 2018 Jan; 336():99-110. PubMed ID: 28866130
[TBL] [Abstract][Full Text] [Related]
6. The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet.
Chen HC; Chen YZ; Wang CH; Lin FJ
J Nutr Biochem; 2020 Mar; 77():108319. PubMed ID: 31926452
[TBL] [Abstract][Full Text] [Related]
7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
8. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Kim S; Hong J; Jeon R; Kim HS
Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
[TBL] [Abstract][Full Text] [Related]
9. Increase in liver cytosolic lipases activities and VLDL-TAG secretion rate do not prevent the non-alcoholic fatty liver disease in cafeteria diet-fed rats.
de Melo AF; Moreira CCL; Sales CF; Rentz T; Raposo HF; Garófalo MAR; Botion LM; Kettelhut IDC; de Oliveira HCF; Chaves VE
Biochimie; 2018 Jul; 150():16-22. PubMed ID: 29705134
[TBL] [Abstract][Full Text] [Related]
10. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
Sun R; Xu D; Wei Q; Zhang B; Aa J; Wang G; Xie Y
Biomed Pharmacother; 2020 Mar; 123():109721. PubMed ID: 31865143
[TBL] [Abstract][Full Text] [Related]
11. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Zhang L; Yang B; Yu B
Biol Pharm Bull; 2015; 38(7):1005-11. PubMed ID: 25972092
[TBL] [Abstract][Full Text] [Related]
12. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
[TBL] [Abstract][Full Text] [Related]
13. Adrenal-specific scavenger receptor BI deficiency induces glucocorticoid insufficiency and lowers plasma very-low-density and low-density lipoprotein levels in mice.
Hoekstra M; van der Sluis RJ; Van Eck M; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e39-46. PubMed ID: 23202366
[TBL] [Abstract][Full Text] [Related]
14. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
[TBL] [Abstract][Full Text] [Related]
15. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
16. Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes.
Veeramani C; Alsaif MA; Al-Numair KS
Biomed Pharmacother; 2017 Dec; 96():1349-1357. PubMed ID: 29174039
[TBL] [Abstract][Full Text] [Related]
17. Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice.
Kroon J; Koorneef LL; van den Heuvel JK; Verzijl CRC; van de Velde NM; Mol IM; Sips HCM; Hunt H; Rensen PCN; Meijer OC
Endocrinology; 2018 Jan; 159(1):535-546. PubMed ID: 28938459
[TBL] [Abstract][Full Text] [Related]
18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
19. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
